ARTBIO (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- December 07, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $90,000,000
Company Info
- Founders
- Emanuele Ostuni, Ph.D
- Company Description
- ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.
- Market
- Cancer therapeutics
- Location
- Cambridge, MA, USA
- Coinvestors
- F-Prime Capital Partners, Omega Funds, Third Rock Ventures